Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
973.00
0.00 (0.00%)
At close: Jul 24, 2025, 3:30 PM KST
KRX:002210 Market Cap
KRX:002210 has a market cap or net worth of 23.24 billion as of July 25, 2025. Its market cap has decreased by -81.59% in one year.
Market Cap
23.24B
Enterprise Value
n/a
Revenue
78.44B
Ranking
n/a
PE Ratio
10.10
Stock Price
973.00
Market Cap Chart
Since August 31, 1995, KRX:002210's market cap has increased from 22.58B to 23.24B, an increase of 2.93%. That is a compound annual growth rate of 0.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 24, 2025 | 23.24B | -78.05% |
Dec 30, 2024 | 105.87B | -19.62% |
Dec 28, 2023 | 131.71B | -13.77% |
Dec 29, 2022 | 152.74B | -22.87% |
Dec 30, 2021 | 198.03B | -32.69% |
Dec 30, 2020 | 294.20B | -22.33% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 75.73T |
Celltrion | 39.84T |
ALTEOGEN | 25.49T |
Yuhan | 9,219.06B |
SK Biopharmaceuticals | 7,987.95B |
Peptron | 6,628.10B |
HLB Co., Ltd. | 6,558.63B |
PharmaResearch | 6,015.61B |